Literature DB >> 16157069

Clinical trials report. Good news and bad news: now the bad news.

Norman M Kaplan.   

Abstract

Year:  2005        PMID： 16157069     DOI： 10.1007/s11906-005-0061-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  12 in total

Review 1.  Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies.

Authors:  S MacMahon; R Collins
Journal:  Lancet       Date:  2001-02-10       Impact factor: 79.321

2.  When are observational studies as credible as randomised trials?

Authors:  Jan P Vandenbroucke
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

3.  Association between cardiovascular outcomes and antihypertensive drug treatment in older women.

Authors:  Sylvia Wassertheil-Smoller; Bruce Psaty; Philip Greenland; Albert Oberman; Theodore Kotchen; Charles Mouton; Henry Black; Aaron Aragaki; Maurizio Trevisan
Journal:  JAMA       Date:  2004-12-15       Impact factor: 56.272

Review 4.  Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.

Authors:  R Collins; S MacMahon
Journal:  Lancet       Date:  2001-02-03       Impact factor: 79.321

5.  Do calcium channel blockers increase the risk of cancer?

Authors:  M Pahor; J M Guralnik; M E Salive; M C Corti; P Carbonin; R J Havlik
Journal:  Am J Hypertens       Date:  1996-07       Impact factor: 2.689

6.  Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial.

Authors:  Philip A Poole-Wilson; Jacobus Lubsen; Bridget-Anne Kirwan; Fred J van Dalen; Gilbert Wagener; Nicolas Danchin; Hanjörg Just; Keith A A Fox; Stuart J Pocock; Tim C Clayton; Michael Motro; John D Parker; Martial G Bourassa; Anthony M Dart; Per Hildebrandt; Ake Hjalmarson; Johannes A Kragten; G Peter Molhoek; Jan-Erik Otterstad; Ricardo Seabra-Gomes; Jordi Soler-Soler; Simon Weber
Journal:  Lancet       Date:  2004 Sep 4-10       Impact factor: 79.321

7.  Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

Authors:  Jan A Staessen; Ji-Guang Wang; Lutgarde Thijs
Journal:  J Hypertens       Date:  2003-06       Impact factor: 4.844

8.  Trial of preventing hypertension: design and 2-year progress report.

Authors:  Stevo Julius; Shawna Nesbitt; Brent Egan; Niko Kaciroti; M Anthony Schork; Melissa Grozinski; Eric Michelson
Journal:  Hypertension       Date:  2004-07-06       Impact factor: 10.190

9.  Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Authors:  Fiona Turnbull
Journal:  Lancet       Date:  2003-11-08       Impact factor: 79.321

10.  The risk of myocardial infarction associated with antihypertensive drug therapies.

Authors:  B M Psaty; S R Heckbert; T D Koepsell; D S Siscovick; T E Raghunathan; N S Weiss; F R Rosendaal; R N Lemaitre; N L Smith; P W Wahl
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.